8 Recruiting Studies Using Tuvusertib
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Tuvusertib
Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302)
📍 University of Arkansas for Medical Sciences — Little Rock, Arkansas
Ovarian Cancer
View Study & Checklist ➔Study of Tuvusertib (M1774) in Combination With DNA Damage Response Inhibitor or Immune Checkpoint Inhibitor (DDRiver Solid Tumors 320)
📍 Providence Medical Foundation — Santa Rosa, California
Metastatic or Locally Advanced Unresectable Solid Tumors
View Study & Checklist ➔Testing the Combination of Two Anticancer Drugs M1774 (Tuvusertib) and Avelumab to Evaluate Their Safety and Effectiveness in Treating Merkel Cell Skin Cancer, MATRiX Trial
📍 UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care — Irvine, California
Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8
View Study & Checklist ➔M9466 Alone or in Combination in Advanced Solid Tumors (DDriver 501)
📍 NEXT Oncology - PARENT — New York, New York
Advanced Solid Tumor
View Study & Checklist ➔Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer
📍 Mayo Clinic Hospital in Arizona — Phoenix, Arizona
Castration-Resistant Prostate Carcinoma
View Study & Checklist ➔Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors
📍 National Cancer Institute Developmental Therapeutics Clinic — Bethesda, Maryland
Advanced Malignant Solid Neoplasm
View Study & Checklist ➔Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
📍 UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care — Irvine, California
Advanced Malignant Solid Neoplasm
View Study & Checklist ➔Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer
📍 Augusta University Medical Center — Augusta, Georgia
Recurrent Endometrial Carcinoma
View Study & Checklist ➔